| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.510300230 |
| P698 | PubMed publication ID | 10421659 |
| P50 | author | Hans M Princen | Q57299407 |
| Mettine Bos | Q78045277 | ||
| P2093 | author name string | F Kuipers | |
| R Havinga | |||
| J P Zoeteweij | |||
| S M Post | |||
| E C de Wit | |||
| P2860 | cites work | SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis | Q24310555 |
| The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor | Q28238069 | ||
| Bile Acid Synthesis in Man: Metabolism of 7α-Hydroxycholesterol-14C and 26-Hydroxycholesterol-3H | Q28364385 | ||
| Suppression of sterol 27-hydroxylase mRNA and transcriptional activity by bile acids in cultured rat hepatocytes | Q28368343 | ||
| Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase in rat hepatocytes | Q28578676 | ||
| Effect of Biliary Drainage on Individual Reactions in the Conversion of Cholesterol to Taurocholic Acid. Bile Acids and Steroids 180 | Q34054626 | ||
| Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice | Q34137756 | ||
| Dietary cholesterol and downregulation of cholesterol 7 alpha-hydroxylase and cholesterol absorption in African green monkeys | Q34150907 | ||
| Identification and characterization of a mouse oxysterol 7alpha-hydroxylase cDNA. | Q34439033 | ||
| Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase. | Q35671417 | ||
| Regulation of cholesterol metabolism in the dog. I. Effects of complete bile diversion and of cholesterol feeding on absorption, synthesis, accumulation, and excretion rates measured during life | Q35899910 | ||
| A fluorimetric and enzymatic method for the estimation of serum total bile acids | Q36622206 | ||
| Secretion of Cholesterol-Rich Lipoproteins by Perfused Livers of Hypercholesterolemic Rats | Q40239048 | ||
| Unexpected inhibition of cholesterol 7 alpha-hydroxylase by cholesterol in New Zealand white and Watanabe heritable hyperlipidemic rabbits. | Q40342532 | ||
| Ketoconazole blocks bile acid synthesis in hepatocyte monolayer cultures and in vivo in rat by inhibiting cholesterol 7 alpha-hydroxylase | Q40919334 | ||
| Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis | Q41098772 | ||
| Bile acid synthesis in hamster hepatocytes in primary culture: sources of cholesterol and comparison with other species | Q41509753 | ||
| Cholesterol is required for secretion of very-low-density lipoprotein by rat liver | Q41825840 | ||
| Cyclosporin A blocks bile acid synthesis in cultured hepatocytes by specific inhibition of chenodeoxycholic acid synthesis | Q42023326 | ||
| Differential feedback regulation of cholesterol 7 alpha-hydroxylase mRNA and transcriptional activity by rat bile acids in primary monolayer cultures of rat hepatocytes | Q42161320 | ||
| Cellular free cholesterol in Hep G2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activity | Q42164591 | ||
| Regulation of sterol 27-hydroxylase and an alternative pathway of bile acid biosynthesis in primary cultures of rat hepatocytes | Q45096819 | ||
| Quantitative estimations of the contribution of different bile acid pathways to total bile acid synthesis in the rat. | Q45108263 | ||
| On the mechanism of stimulation of cholesterol 7 alpha-hydroxylase by dietary cholesterol. | Q45128967 | ||
| Enterohepatic circulation in the rat. | Q51831340 | ||
| Effect of lymphatic drainage on 7alpha-hydroxylation of cholesterol in rat liver | Q67435250 | ||
| 46 Reversed-phase high-performance liquid chromatography assay of cholesterol 7α-hydroxylase | Q67842858 | ||
| Potential bile acid precursors in plasma--possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in man | Q68562278 | ||
| The role of acyl-CoA: cholesterol acyltransferase in the metabolism of free cholesterol to cholesteryl esters or bile acids in primary cultures of rat hepatocytes | Q69052301 | ||
| Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver | Q71257654 | ||
| Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. CI-1011: an acyl sulfamate with unique cholesterol-lowering activity in animals fed noncholesterol-supplemented diets | Q71935042 | ||
| Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 6. The first water-soluble ACAT inhibitor with lipid-regulating activity | Q72289344 | ||
| Regulation of hepatic 7 alpha-hydroxylase expression and response to dietary cholesterol in the rat and hamster | Q72631412 | ||
| ACAT inhibitor HL-004 accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats (SHRSP): stimulation of bile acid production by HL-004 | Q73589925 | ||
| Increased bile acid pool inhibits cholesterol 7 alpha-hydroxylase in cholesterol-fed rabbits | Q73933606 | ||
| CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys | Q74449512 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 491-500 | |
| P577 | publication date | 1999-08-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat | |
| P478 | volume | 30 |
| Q35049074 | ACAT inhibitors: the search for a novel and effective treatment of hypercholesterolemia and atherosclerosis. |
| Q45108836 | ACAT2 deficiency limits cholesterol absorption in the cholesterol-fed mouse: impact on hepatic cholesterol homeostasis |
| Q36941874 | Apigenin Ameliorates Dyslipidemia, Hepatic Steatosis and Insulin Resistance by Modulating Metabolic and Transcriptional Profiles in the Liver of High-Fat Diet-Induced Obese Mice |
| Q28115475 | Decreased Expression of ARV1 Results in Cholesterol Retention in the Endoplasmic Reticulum and Abnormal Bile Acid Metabolism* |
| Q37402144 | Different responsiveness to a high-fat/cholesterol diet in two inbred mice and underlying genetic factors: a whole genome microarray analysis |
| Q64278282 | Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice |
| Q44386370 | Dual action of neutral sphingomyelinase on rat hepatocytes: activation of cholesteryl ester metabolism and biliary cholesterol secretion and inhibition of VLDL secretion |
| Q44005775 | Effect of SMP-500, a novel ACAT inhibitor, on hepatic cholesterol disposition in rats |
| Q44297587 | Effects of dietary soybean lecithin on plasma lipid transport and hepatic cholesterol metabolism in rats |
| Q44300074 | Effects on apoB-100 secretion and bile acid synthesis by redirecting cholesterol efflux from HepG2 cells |
| Q36449144 | Influence of the Alcohol Present in a Phytotherapic Tincture on Male Rat Lipid Profiles and Renal Function. |
| Q24648243 | Inhibition of acyl-coenzyme A:cholesterol acyltransferase stimulates cholesterol efflux from macrophages and stimulates farnesoid X receptor in hepatocytes |
| Q45712469 | Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor |
| Q44909834 | Over-expression of hepatic neutral cytosolic cholesteryl ester hydrolase in mice increases free cholesterol and reduces expression of HMG-CoAR, CYP27, and CYP7A1. |
| Q39841745 | Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion |
| Q64119960 | The APOE3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis |
Search more.